Navigation Links
DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC

s based on non-toxic subunits are being developed, including BT-VACC™.

About DOR BioPharma, Inc.

DOR BioPharma, Inc. is a biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal ("GI") diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid being developed for the treatment of GI graft-versus-host disease ("GVHD"), a common and potentially life-threatening complication of bone marrow transplantation. DOR has filed an NDA with the FDA for the treatment of GI GVHD, and has received a PDUFA date of July 21, 2007. An MAA with the EMEA for orBec® has also been filed and validated. orBec® may also have application in treating other gastrointestinal disorders characterized by severe inflammation. DOR has also recently initiated a clinical development program with its Lipid Polymer Micelle ("LPMTM") oral drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the recently enacted Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines designed to protect against the lethal effects of exposure to ricin toxin and botulinum toxin. DOR's ricin toxin vaccine, RiVax™, has been shown to be safely tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers.

For further information regarding DOR BioPharma, please visit the Company's website located at www.dorbiopharma.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, that reflect DOR BioPharma, Inc.'s current expectations about its future r
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:10/30/2014)... 30, 2014 Molecular Profiles Ltd., a subsidiary ... and Maryland -based Xceleron have announced ... during clinical development that will be launched at AAPS ... This partnership extends Molecular Profiles, new ROADMAP ... earlier this month. The company also has complementary collaborations ...
(Date:10/30/2014)... , October 30, 2014 ... GG hilft beim Aufbau von Kuhmilchverträglichkeit     ... für Lebensmittelallergien bei Säuglingen und Kleinkindern. Der ... bei der Ernährung der Babys bzw. deren ... sich jedoch, dass sich bei einer beträchtlichen ...
(Date:10/30/2014)... 29, 2014 nebulizer is a medical device ... and cystic fibrosis) that converts liquid medication into mist ... the lungs of a patient when inhaled through the ... is dominated by various devices powered by electric current ... asthma, COPD and cystic fibrosis and growing number of ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3
... ... (commonly referred to as heart disease) is the leading cause of death for ... heart disease. Despite the prevalence of heart disease in women, a 2005 American ... cardiologists were not aware of the fact that more women than men die ...
... WESTFORD, Mass. , Feb. 9 LightLab Imaging, ... Tomography (OCT) for coronary artery applications, today reported that Trial ... for the commencement of the next phase of an ... Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc. ...
Cached Medicine Technology:Awareness of Heart Disease in Women Remains Low 2Awareness of Heart Disease in Women Remains Low 3Awareness of Heart Disease in Women Remains Low 4Awareness of Heart Disease in Women Remains Low 5Awareness of Heart Disease in Women Remains Low 6Awareness of Heart Disease in Women Remains Low 7Date Set for LightLab Damages Trial Against Volcano and Axsun 2
(Date:10/30/2014)... 2014 PreDiabetes Centers , the ... shoppers with a supply of sugardown®, a chewable ... post-meal blood sugar spikes. Learning how to control blood ... part of a diabetes prevention plan. , Shoppers who ... complimentary tube of sugardown. The offer expires November 30. ...
(Date:10/30/2014)... Radio listeners who indicate use of ... impact of traditional radio commercials and have overwhelmingly endorsed ... influence a purchasing decision. , Those are some highlights ... by radio marketing company CRN International. The research is ... of respondents who indicated they have purchased or considered ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Home Care ... leading provider of non-medical, in-home senior care, is weighing ... increased brain health. , The study, performed by the ... of 60 and 78 over a week-long period and ... to daily physical activity. By examining the structural soundness ...
(Date:10/30/2014)... FL (PRWEB) October 30, 2014 ... offering therapeutic horseback riding to special needs individuals in ... Round-Up on Saturday, November 15 from 10-2:00 p.m. at ... event is open to the public and is designed ... , Admission to the HSS Round-Up is free. ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2
... loss surgery has more benefits that simply reducing the fat. ... the McGill University// . ,The researchers studied ... study followed these people from 1986 to 2002. All patients ... with 5,700 people who did not undergo such surgery. ...
... at improving women's health researchers are facing a major ... participation in food trials and studies. ,Food ... lack of available women's research at this week's Institute ... world's largest annual meeting on food science, business and ...
... the June 26 issue of Archives of Internal Medicine, which ... have severe hot flashes// may have more chronic sleep problems ... that almost 85% of women in menopause experience hot flashes, ... It was explained that hot flashes often occur during the ...
... researchers at the University of Central Florida and University of ... space and how it affects the astronauts' health. ... aboard the Space Shuttle Discovery. The flies will need ... is scheduled to launch Saturday, July 1, from Kennedy Space ...
... down the catwalk alongside eight blind girl students at a ... are on for the show 'Light Up the World' slated ... Guwahati. Young fashion designer Himangshu Bora is busy training the ... have supermodels Nina Manuel and Dippanita Sharma for company that ...
... announced on Wednesday that as many as three million ... Southern Africa. //WFP executive director James Morris said that ... a distribution problem. ,"Good harvests do not ... "Food and good nutrition are crucial in battling against ...
Cached Medicine News:Health News:Women Doubtful of Food Research Benefiting Them 2Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Effect of Prolonged Stay in Space Studied Using Fruit Flies 2Health News:Effect of Prolonged Stay in Space Studied Using Fruit Flies 3Health News:Blind Girl Students to Catwalk in Guwahati Fashion Show 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: